A System Dynamics Model of Violent Trauma and the Role of Violence Intervention Programs.


Journal

The Journal of surgical research
ISSN: 1095-8673
Titre abrégé: J Surg Res
Pays: United States
ID NLM: 0376340

Informations de publication

Date de publication:
03 2020
Historique:
received: 03 07 2019
revised: 26 09 2019
accepted: 02 10 2019
pubmed: 11 11 2019
medline: 11 6 2020
entrez: 11 11 2019
Statut: ppublish

Résumé

Violence intervention programs (VIPs) can reduce interpersonal violence (IPV); however, optimizing the implementation of VIPs is challenging, given the complex dynamics of IPV. System dynamics models (SDMs) provide a means of visualizing dynamic and causal relationships in such complex systems. We use the IPVSDM to characterize and examine the relationship between IPV, VIPs, and the social determinants of health (SDH). The simulation model was created from a diagram that links putative causal relationships between VIPs, SDH, and IPV events. Simulation rules are then used to calculate a risk of violence parameter based on the SDH, which drives the transition from low-risk to high-risk populations and in turn influences IPV event rates. A qualitative relational approach was used to evaluate long-term effects of VIP on IPV events. The model produced qualitatively plausible behavior with respect to IPV events, population transitions, and relative overall VIP effect. Simulation runs converged to stable steady states with an exponential benefit of VIP on reducing IPV that is best appreciated after 1-2 y. The VIP functioned in a recognizable fashion by slowing the shift from low-risk to high-risk populations. This initial implementation of the IPVSDM produced recognizable baseline behavior while incorporating the possible effects of a VIP. The model allows causality and counterfactual testing, which is impractical in vivo. Community-level VIP efforts should show benefit particularly after a couple years. Future work will emphasize adding complexity to the IPVSDM and identifying real-world metrics to aid in testing, validation, and prediction of the model.

Sections du résumé

BACKGROUND
Violence intervention programs (VIPs) can reduce interpersonal violence (IPV); however, optimizing the implementation of VIPs is challenging, given the complex dynamics of IPV. System dynamics models (SDMs) provide a means of visualizing dynamic and causal relationships in such complex systems. We use the IPVSDM to characterize and examine the relationship between IPV, VIPs, and the social determinants of health (SDH).
MATERIALS AND METHODS
The simulation model was created from a diagram that links putative causal relationships between VIPs, SDH, and IPV events. Simulation rules are then used to calculate a risk of violence parameter based on the SDH, which drives the transition from low-risk to high-risk populations and in turn influences IPV event rates. A qualitative relational approach was used to evaluate long-term effects of VIP on IPV events.
RESULTS
The model produced qualitatively plausible behavior with respect to IPV events, population transitions, and relative overall VIP effect. Simulation runs converged to stable steady states with an exponential benefit of VIP on reducing IPV that is best appreciated after 1-2 y. The VIP functioned in a recognizable fashion by slowing the shift from low-risk to high-risk populations.
CONCLUSIONS
This initial implementation of the IPVSDM produced recognizable baseline behavior while incorporating the possible effects of a VIP. The model allows causality and counterfactual testing, which is impractical in vivo. Community-level VIP efforts should show benefit particularly after a couple years. Future work will emphasize adding complexity to the IPVSDM and identifying real-world metrics to aid in testing, validation, and prediction of the model.

Identifiants

pubmed: 31706544
pii: S0022-4804(19)30732-2
doi: 10.1016/j.jss.2019.10.015
pmc: PMC7028446
mid: NIHMS1545760
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

258-263

Subventions

Organisme : NCATS NIH HHS
ID : TL1 TR002388
Pays : United States
Organisme : NIBIB NIH HHS
ID : U01 EB025825
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

J Trauma. 1989 Jul;29(7):940-6; discussion 946-7
pubmed: 2746704
Inj Epidemiol. 2016 Dec;3(1):22
pubmed: 27747558
Am J Public Health. 2006 Mar;96(3):452-8
pubmed: 16449591
Nurs Res. 2017 Sep/Oct;66(5):399-404
pubmed: 28858148
Arch Surg. 2000 Jul;135(7):837-43
pubmed: 10896379
MMWR Suppl. 2016 Feb 12;65(1):57-60
pubmed: 26916848
J Trauma Acute Care Surg. 2014 Jul;77(1):123-8
pubmed: 24977766
Curr Epidemiol Rep. 2019 Jun 15;6:248-262
pubmed: 31911889
Am Surg. 2012 Sep;78(9):1000-4
pubmed: 22964211
J Trauma. 2004 Oct;57(4):872-6
pubmed: 15514545
PLoS One. 2017 Aug 16;12(8):e0182441
pubmed: 28813444
Eur J Trauma Emerg Surg. 2018 Dec;44(6):851-858
pubmed: 28326453
Inj Prev. 2010 Oct;16(5):327-32
pubmed: 20587814
J Trauma Acute Care Surg. 2018 Jan;84(1):175-182
pubmed: 28787376
J Urban Health. 2013 Feb;90(1):27-40
pubmed: 22696175
Soc Sci Med. 2013 Sep;93:247-55
pubmed: 23123169
J Trauma. 2006 Sep;61(3):534-7; discussion 537-40
pubmed: 16966983
Eur J Trauma Emerg Surg. 2014 Dec;40(6):701-6
pubmed: 26814785
J Urban Health. 2015 Jun;92(3):490-501
pubmed: 25952137
Prog Community Health Partnersh. 2011 Spring;5(1):67-75
pubmed: 21441670
J Surg Res. 2016 Jul;204(1):261-6
pubmed: 27451895
WMJ. 2007 Oct;106(7):394-6
pubmed: 18030827
Ann Surg. 2017 May;265(5):847-853
pubmed: 27280506

Auteurs

Justin Cirone (J)

Department of Surgery, The University of Chicago, Chicago, Illinois.

Peter Bendix (P)

Department of Surgery, The University of Chicago, Chicago, Illinois.

Gary An (G)

Department of Surgery, The University of Vermont, Burlington, Vermont. Electronic address: docgca@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH